As Signum Surgical pursues broader commercialization to increase patient access to the FDA De Novo-authorized BioHealx® Anal Fistula Device, it is continuing to expand the clinical evidence supporting BioHealx Assisted Fistula Treatment (BAFT™). An ongoing multicenter post-market clinical study is
Bryn Mawr, PA — A Main Line Health team has become the first in Pennsylvania to implant a new, cutting-edge device for a challenging condition that causes a painful, sometimes debilitating condition in the rectal area and has long frustrated
Northwell’s Staten Island University Hospital Performs First U.S. Procedure with New BioHealx® Device for Complex Anal Fistulas STATEN ISLAND, N.Y. – (BUSINESS WIRE August 6, 2025) Northwell’s Staten Island University Hospital (SIUH) is the first medical center in the United
Please get in touch with us using this form.
"*" indicates required fields
